Wholly owned subsidiary of Alif Holding to focus on maritime protection, smart ports, underwater intelligence and critical infrastructure protection; Dr. Jasem Al-Mansory expected to serve as ChairmanABU DHABI, UAE, Sept. 9, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ:AIIO) ("Robo.ai" or the "Company") today announced that Alif Holding, the Company's industrial group, plans to establish Alif Maritec as a wholly owned subsidiary in the United Arab Emirates. The new company will focus on marine security and intelligent maritime infrastructure. Dr. Jasem Al-Mansory, Chief Executive Officer of Alif Holding, is expected to serve as Chairman of Alif Maritec. Alif Maritec w
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- Robo.ai Announces Proposed Establishment of Alif Maritec, a Marine Security and Intelligent Maritime Infrastructure Company
- Flotek Raises 2026 Guidance Again on Continued Strength of International Sales
HOUSTON, Sept. 9, 2026 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK) today announced an increase to its previously disclosed guidance estimates for 2026 total revenue and Adjusted EBITDA. Following strong second-quarter results, on August 4, 2026, the Company raised its full-year 2026 guidance for total revenue to a range of $340 million to $350 million and for Adjusted EBITDA(1) to a range of $47 million to $51 million. As a result of the current outlook for international chemistry sales in the second half of 2026, the Company expects 2026 total revenue of $360 million to $370 million and Adju
- Health In Tech Named to Newsweek's America's Greatest Mid-Market Companies 2026
Health In Tech recognized among the 100 highest-scoring U.S. public mid-market companies following an initial review of approximately 4,300 companies, based on financial strength, workforce performance, innovation and sustainabilitySTUART, Fla., Sept. 9, 2026 /PRNewswire/ -- Health In Tech, Inc. (NASDAQ:HIT), an AI-enabled InsurTech platform company, announced today that it has been named one of Newsweek's America's Greatest Mid-Market Companies 2026. The ranking, developed by Newsweek in partnership with Plant-A Insights Group, recognizes the 100 highest-scoring publicly listed U.S. mid-market companies based on a comprehensiv
- CGI acquires Callibrity, strengthening presence in Cincinnati and expanding production-ready AI and platform engineering capabilities
Stock Market Symbols GIB.A (TSX) GIB (NYSE) cgi.com/newsroomCINCINNATI, Sept. 9, 2026 /CNW/ -- CGI (TSX:GIB) (NYSE:GIB), one of the world's largest independent technology and professional services firms, today announced the acquisition of Callibrity, strengthening CGI's presence in Cincinnati and expanding the company's capabilities in production-ready enterprise AI, platform engineering and digital product development. The transaction closed on September 8, 2026. Founded in 2007, Callibrity is an end-to-end technology consulting firm that brings together developers, strategists and engineers to help clients solve complex technology challenges. The firm works across commercial industries, wi
- VIAVI to Showcase End-to-End Data Center Testing Portfolio Enabling Scale-Up, Scale-Out and Scale-Across to 1.6T and Beyond at ECOC 2026
Demonstrations to include L0-3 and AI fabric validation, CPO and Silicon Photonics testing, quantum and hybrid network evaluation, and fiber inspection, cleaning and monitoring solutionsCHANDLER, Ariz., Sept. 9, 2026 /PRNewswire/ -- VIAVI Solutions Inc. (VIAVI) (NASDAQ:VIAV) will showcase its end-to-end data center portfolio for foundational silicon technologies, modules and systems testing at booth 1001 at ECOC 2026 from September 21-23 at the FYCMA exhibition center in Malaga, Spain. Hyperscalers and cloud providers continue to push the boundaries of network speed and capacity as they scale AI infrastructure. 1.6T technologie
- Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year
Notable additional benefit observed with an added reduction in MADRS1 score leading to an average 13-point reduction from baseline at Week 52 with durability extended out to 1 year for participants who were randomized to the 25 mg arm and received an additional dose For participants randomized to Placebo arm who received first dose of COMP360 25 mg in open-label Part C, data further reinforces that a single 25 mg dose can produce rapid onset, meaningful effect and durability For all participants in Part C who received a 25 mg open-label dose, strong response and remission rates were observed with 40%-45% responders2 and approximately 30% remitters3 across all timepoints 6 weeks post
- Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference
MELBOURNE, Australia and INDIANAPOLIS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ:TLX, "Telix") advises that Dr. Christian Behrenbruch, Managing Director and Group CEO and Kevin Richardson, CEO, Precision Medicine will present at the upcoming Morgan Stanley 24th Annual Global Healthcare Conference and at the H.C. Wainwright 28th Annual Global Investment Conference, both in New York, NY. Presentation details: Morgan Stanley 24th Annual Global Healthcare ConferenceDate: September 14, 2026Time: 9:15 a.m. EDT (11:15 p.m. AEST) H.C. Wainwright 28th Annual Global Investment ConferenceDate: September 15, 2026Time: 10:30 a.m. EDT (12:30 a.m. AEST, Sep 16)
- MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management
Collaboration combines Rose Pharma investigational rapid-acting GLP-1 receptor agonist with MannKind’s Technosphere® inhalation technologyMannKind to receive an equity interest and potential royalties while providing pharmaceutical development and manufacturing support through completion of a Phase 1b clinical study DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD), a biopharmaceutical company focused on developing innovative, patient-centric therapies for chronic diseases, and Rose Pharma Inc. (Rose Pharma) today announced that they have entered into a worldwide licensing and collaboration agreement to develop ROSE-010 Tech
- Albertsons® Companies, Inc. Appoints Meg Whitman as Executive Chair
Kim Fennebresque named Lead Independent Director Whitman brings over 40 years of business, technology and strategic innovation experience to Albertsons Cos. as the retailer embarks on a defining period in its history Albertsons® Companies, Inc. (NYSE:ACI) today announced that Meg Whitman has been appointed to the newly created role of Executive Chair of the company’s Board of Directors. With Whitman’s appointment, Kim Fennebresque has transitioned from Chair to Lead Independent Director, and the board has expanded from 10 to 11 members. Whitman will work to support Susan Morris, CEO of Albertsons Cos., and her entire senior team. This press release features multimedia. View the full re
- Kyushu Electric Power Advances Strategic Investment in ProLogium, Deepening Collaboration in Next-Generation Batteries and Energy Sector
TAOYUAN, Taiwan, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ProLogium today announced a further deepening of its long-term strategic partnership with Kyushu Electric Power Co., Inc. (Kyushu Electric Power). Following ongoing collaboration across energy, next-generation batteries and related industrial fields, Kyushu Electric Power is now moving forward with a strategic investment in ProLogium, extending the relationship from industrial collaboration to strategic capital participation. Built on a long-standing foundation of cooperation and mutual trust, this deepening relationship further strengthens the strategic ties between the two companies and underscores their shared confidence in the long-te
- Vertical Aerospace to Participate in Upcoming Investor Conferences
Vertical Aerospace Ltd. ("Vertical" or the "Company") (NYSE:EVTL), a global aerospace and technology company pioneering electric aviation, today announced that its Chief Executive Officer, Stuart Simpson, will participate in the following investor conferences in New York City: Jefferies Global Industrials Conference (Wednesday, September 9, 2026) Fireside chat scheduled for 2:50 pm ET Deutsche Bank 16th Annual Aviation Forum: Airlines, Lessors, Manufacturers (Thursday, September 10, 2026) H.C. Wainwright Global Investment Conference (Monday, September 14 - Wednesday, September 16, 2026) Management will be holding meetings with investors during all three events. During the
- JinkoSolar Announces Proposed Change of Company Name to Jinko Holdings Limited and Provides Strategic Investment Update
SHANGRAO, China, Sept. 9, 2026 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE:JKS), today announced that its board of directors (the "Board") has approved a proposal to change the Company's English name to "Jinko Holdings Limited" and adopt "晶科控股有限公司" as its dual foreign name (the "Proposed Name Change"). The Proposed Name Change is subject to the approval of the Company's shareholders at its annual general meeting to be held on October 21, 2026, and to the completion of applicable regulatory procedures. Following completion of the Proposed Name Change, the Company's American depositary shares are expected to continue trading on the New York Stock Exchange
- JinkoSolar Schedules 2026 Annual General Meeting to be Held on October 21, 2026
SHANGRAO, China, Sept. 9, 2026 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. (the "Company," or "JinkoSolar") (NYSE:JKS), today announced that it will hold its 2026 annual general meeting on Wednesday, October 21, 2026 at 10:00 a.m. (Beijing time) at 10F, No.1, Lane 1466, Shenchang Road, Minhang District, Shanghai, China, for the following purposes: To re-elect Mr. Gang Chu as an independent director of the Company;To re-elect Mr. Steven Markscheid as an independent director of the Company;To ratify the appointment of PricewaterhouseCoopers Zhong Tian LLP as auditors of the Company for the fiscal year of 2026;To authorize the directors of the Company to determine the remuneration of the Compa
- SmartStop 3PM Launches With a Simple Promise: Smarter Management. Stronger Results.
Formerly ArgusPSM, the third-party management platform unifies under the SmartStop brand while preserving the flexibility, independence, and customized service owners value. SmartStop Self Storage REIT, Inc. ("SmartStop") (NYSE:SMA), an internally managed real estate investment trust and a premier owner and operator of self-storage facilities in the United States and Canada, announced that its third-party management platform, formerly Argus Professional Storage Management Powered by SmartStop, has been rebranded as SmartStop 3PM. The new name aligns the platform with the strength and recognition of the SmartStop brand while reinforcing the principle at the heart of the business: giving in
- Sysco Reaffirming Fiscal 2027 Guidance; Introducing $500 Million Multi-Year AI Powered Efficiency Program; Raising Mid-Term Financial Algorithm Targets
HOUSTON, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) ("Sysco" or the "Company") is reaffirming its fiscal 2027 financial guidance (originally issued on August 4, 2026) ahead of the Company’s webcast presentation from the Barclays 19th Annual Global Consumer Staples Conference in Boston scheduled for today, Wednesday, September 9, at 12:00 p.m. ET. The live conference webcast can be accessed at investors.sysco.com. Re-affirming fiscal 2027 guidance including 9% to 11% adjusted EPS growth (on a 53 week basis)Introducing target of at least $500 million for AI powered efficiency to be realized by fiscal year 2029Raising mid-term guidance range for net sales growth of 4%-7%
- IDEAYA Biosciences and Servier Announce First Patient Dosed in OptimUM-11 Global Phase 3 Registrational Trial of Darovasertib and Crizotinib as Adjuvant Therapy for Subjects with Uveal Melanoma
Global Phase 3 trial will evaluate the darovasertib and crizotinib combination in primary uveal melanoma patients with increased risk of metastasis following completion of local therapyOptimUM-11 expands development of darovasertib across the uveal melanoma patient journey into the adjuvant setting, where there is a significant unmet need for systemic treatment options designed to reduce the risk of metastatic recurrenceSOUTH SAN FRANCISCO, Calif., Sept. 9, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), a leading precision medicine oncology company, and Servier, an independent international pharmaceutical group governed by a foundation, today announced that the first patient ha
- The Cigna Group to Host Investor Day on September 30
BLOOMFIELD, Conn., Sept. 9, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will host its Investor Day on Wednesday, September 30, 2026. The event will begin at 8:30 a.m. ET, featuring in-depth presentations on corporate strategy and financial targets. A live webcast of the presentation will be available at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Investor Relations section of The Cigna Group's website.To listen to this presentation live on the internet, visit https://investors.thecignagroup.com/events-and-presentations/default.aspx at least 15 minutes prior to the pr
- BMO: Commission-Free Stock and ETF Trades with BMO InvestorLine
BMO InvestorLine combines its lowest fees ever with access to advanced trading tools, professional research and market insights, empowering investors with a more accessible intelligent investing platformUnlimited $0 commissions on all stock and ETF trades.Lower options trading costs, with $0 commissions and reduced per-contract fee of $0.90, down from $1.25.Elimination of all brokerage account administration fees.TORONTO, Sept. 9, 2026 /CNW/ -- BMO InvestorLine is making its digital investing experience even better, announcing today the introduction of unlimited commission-free trading on all stocks, ETFs and options, the elimination of all brokerage account administration fees and the reduc
- Independence Realty Trust and Centerspace to Merge in $8.1 Billion Combination
Creating a leading middle-market apartment REIT with greater scale, broader geographic diversification, and an expanded value-add growth pipeline — positioned to deliver attractive risk-adjusted returns with no additional leverage. Transaction Highlights Creates a leading public residential REIT with a pro forma equity market capitalization of approximately $5.0 billion and an enterprise value of approximately $8.1 billion, with more than 44,000 apartment units in the combined portfolio Increases geographic diversification across high-growth markets, with 58% of pro forma NOI derived from Sunbelt markets, 27% from Midwest markets, and 15% from Mountain West markets Expands margin
- KRISPY KREME® Sweetens Season with NEW Apple Cider Original Glazed® Doughnut and Fall & Football Dozen
Fans can score a dozen Apple Cider Original Glazed Doughnuts for just $5 with the purchase of any dozen at a regular price, Sept. 10-13 Fall flavors are here and football is back – and Krispy Kreme® is making both even sweeter. Beginning Thursday, Sept. 10, fans can enjoy the NEW Apple Cider Original Glazed® Doughnut and a Fall & Football Dozen made for game day gatherings, watch parties and all the delicious moments of the season. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260909499646/en/Fans can score a dozen Apple Cider Original Glazed Doughnuts for just $5 with the purchase of any dozen at a regular price, Sept. 10-13